Mini Review
Cost of Biotech Drug Development and Affordability Issues in LMICs
Abdul Kader Mohiuddin*
Department of Pharmacy, World University of Bangladesh, Bangladesh
Abdul Kader Mohiuddin, Department of Pharmacy, World University of Bangladesh, Bangladesh
Received Date:July 16, 2019; Published Date:July 29, 2019
Abstract
Pharmaceutical companies invest in the development and testing of their drugs including by funding clinical trials. Furthermore, pharmaceutical companies also spend a large amount of money on advertising. For instance, in 2016 US$6.7 billion was spent on direct-to-consumer pharmaceutical advertising alone in the USA [1]. Worldwide spending on medicines reached $1.2 trillion in 2018 and will exceed $1.5 trillion by 2023, according to “The Global Use of Medicine in 2019 and Outlook to 2023” [2,3].
-
Abdul Kader Mohiuddin. Cost of Biotech Drug Development and Affordability Issues in LMICs. Arch Biomed Eng & Biotechnol. 2(3): 2019. ABEB.MS.ID.000538
-
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.